US Supreme Court Strikes Down Gene Patents but Allows Patenting of Synthetic DNA | GenomeWeb

NEW YORK (GenomeWeb News) – The US Supreme Court today unanimously ruled that human genes are not patentable, but synthetic DNA, or cDNA, is patent eligible because it does not occur naturally.

The decision, written by Justice Clarence Thomas, was hailed by the plaintiffs in the case, Association for Molecular Pathology et al. v. Myriad Genetics, who view it as a victory for patients seeking greater access to genetic testing and researchers aiming to develop new molecularly guided personalized treatments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.